Antibody Discovery

Utilizing multiple technology platforms, LakePharma offers a range of services and solutions to identify novel monoclonal antibodies and determine their sequences. 

1. Hybridoma technology: comprehensive, customized hybridoma campaigns for therapeutic antibody discovery.

2. Synthetic and naïve phage antibody libraries: LakePharma has licensed the best synthetic scFv (Distributed Bio) and naïve Fab (XOMA) libraries and employs them for unparalleled  de novo antibody discovery.  

3. Clonal B cells:  B cell clones or single cells can be used as the starting point for molecular cloning.

4. De novo sequencing: mass spectrometry can be used to sequence antibodies when the starting material is a pure monoclonal antibody and the source of DNA is not available.   

Please contact LakePharma at inquiries@lakepharma.com for custom quotes and details.